Ignite Creation Date:
2024-05-05 @ 11:21 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00000652
Status:
COMPLETED
Last Update Posted:
2012-11-01
First Post:
1999-11-02
Brief Title:
A Phase I Study to Evaluate the Safety and Toxicity of the Combination of Zidovudine and 23-Dideoxyinosine Didanosine in Children With HIV Infection
Sponsor:
National Cancer Institute NCI
Organization:
National Institute of Allergy and Infectious Diseases NIAID
Organization Data
Organization:
National Institute of Allergy and Infectious Diseases NIAID
Class:
NIH
Study ID:
ACTG 176
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
National Cancer Institute NCI
Lead Sponsor Class:
NIH
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None